US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

Voluntary Benefits Suits Emerge As New ERISA Battleground No Photo Available

Kellie Mejdrich

A recent crop of proposed class actions targeting employers' insurance-related voluntary benefits offerings — for things like critical... (more story)

J&J $5.5B Talc MDL Deal, $25.4M Cooley Judgment And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at Johnson & Johnson's $5.5 billion commitment in a proposed settlement to resolve thousands of suit... (more story)

This Week's Healthcare Earnings: Tenet, CHS, AstraZeneca No Photo Available

Yeji Jesse Lee

Healthcare providers and drugmakers posted results for the second quarter of 2026 this past week, giving investors a closer look at ho... (more story)